Schmitz Robin, Willeke Frank, Barr Justin, Scheidt Michael, Saelzer Heike, Darwich Ibrahim, Zani Sabino, Stephan Dietmar
Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Department of General, Visceral and Vascular Surgery, Section Minimal Invasive Surgery and Robotics, St. Marien - Krankenhaus, Siegen, Germany.
Surg Technol Int. 2019 May 15;34:243-249.
This retrospective study was performed to evaluate the safety and feasibility of the new Senhance Robotic System (TransEnterix Inc., Morrisville, North Carolina) for inguinal hernia repairs using the transabdominal preperitoneal approach.
From March to September 2017, 76 inguinal hernia repairs in 64 patients were performed using the Senhance Robotic System. Patients were between 18 and 90 years of age, eligible for a laparoscopic procedure with general anesthesia, had no life-threatening disease with a life expectancy of less than 12 months, and a body mass index (BMI) < 35. A retrospective chart review was performed for a variety of pre-, peri-, and postoperative data including, but not limited to, patient demographics, hernia characteristics, and intraoperative and postoperative complications.
Fifty-four male and 10 female patients were included in the study. Median age was 56.5 years (range 22-86 years), and median BMI was 25.9 kg/m2 (range 19.5-31.8 kg/m2). Median docking time was seven minutes (range 2-21 minutes), and median operative time was 48 minutes (range 18-142 minutes). Two cases were converted to standard laparoscopic surgery due to robot malfunction and abdominal wall bleeding, respectively. Median length of stay was one day.
We report the first series of laparoscopic inguinal hernia repairs using the new Senhance Robotic System. Compared to conventional laparoscopic transabdominal preperitoneal (TAPP) hernia repairs, there was no significant difference in operative time or perioperative complications. Additionally, there was no significant learning curve detected due to its intuitive applicability. Therefore, the Senhance Robotic System promises broad applicability across a range of laparoscopic general surgical operations.
本回顾性研究旨在评估新型Senhance机器人系统(TransEnterix公司,北卡罗来纳州莫里斯维尔)经腹腹膜前入路修补腹股沟疝的安全性和可行性。
2017年3月至9月,使用Senhance机器人系统对64例患者进行了76例腹股沟疝修补术。患者年龄在18至90岁之间,符合全身麻醉下的腹腔镜手术条件,无预期寿命小于12个月的危及生命疾病,体重指数(BMI)<35。对各种术前、术中和术后数据进行了回顾性图表分析,包括但不限于患者人口统计学、疝的特征以及术中及术后并发症。
研究纳入了54例男性和10例女性患者。中位年龄为56.5岁(范围22 - 86岁),中位BMI为25.9 kg/m²(范围19.5 - 31.8 kg/m²)。中位对接时间为7分钟(范围2 - 21分钟),中位手术时间为48分钟(范围18 - 142分钟)。分别有2例因机器人故障和腹壁出血转为标准腹腔镜手术。中位住院时间为1天。
我们报告了首例使用新型Senhance机器人系统进行的腹腔镜腹股沟疝修补术系列病例。与传统腹腔镜经腹腹膜前(TAPP)疝修补术相比,手术时间或围手术期并发症无显著差异。此外,由于其直观的适用性,未检测到明显的学习曲线。因此,Senhance机器人系统有望广泛应用于一系列腹腔镜普通外科手术。